NCT03447821View on ClinicalTrials.gov

Efficacy and Safety of CB-01-11 200mg Tablets in Infectious Diarrhoea

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Infectious Diarrhoea
Interventions
DRUG

400 mg Rifamycin SV dosage

DRUG

800 mg Rifamycin SV dosage

DRUG

1200 mg Rifamycin SV dosage

Sponsors
All Listed Sponsors
lead

Cosmo Technologies Ltd

INDUSTRY

NCT03447821 - Efficacy and Safety of CB-01-11 200mg Tablets in Infectious Diarrhoea | Biotech Hunter | Biotech Hunter